CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2800
0.00 (0.00%)
At close: Dec 26, 2025
CytoDyn Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
353.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | - | - | - |
| May 31, 2024 | - | - | - |
| May 31, 2023 | - | - | - |
| May 31, 2022 | 266.00K | - | - |
| May 31, 2021 | - | - | - |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
CytoDyn News
- 12 days ago - CytoDyn (CYDY) Anticipates Significant Progress in 2026 - GuruFocus
- 12 days ago - December 2025 Letter to Shareholders - GlobeNewsWire
- 20 days ago - CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium - GlobeNewsWire
- 27 days ago - CytoDyn Announces Resolution of Class Action Lawsuit - GlobeNewsWire
- 4 weeks ago - CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium - GlobeNewsWire
- 7 weeks ago - CytoDyn (CYDY) Secures $30 Million Funding Commitment from Yorkville - GuruFocus
- 7 weeks ago - CytoDyn (CYDY) Secures $30M Funding for Cancer Drug Development - GuruFocus
- 7 weeks ago - CytoDyn secures $30M equity funding commitment - Seeking Alpha